References
Jones, R. N., Fuchs, P. C.: In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 1976, 10: 146–149.
Van Caekenberghe, D. L., Pattyn, S. R.: In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrobial Agents and Chemotherapy 1984, 25: 518–521.
Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay o 9867, a new quinoline derivative compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.
Barry, A. L., Jones, R. N., Thornsberry, C., Ayers, L. W., Gerlach, E. H., Sommers, H. M.: Antibacterial activity of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid. Antimicrobial Agents and Chemotherapy 1984, 25: 633–637.
Muytjens, H. L., Van Der Ros-Van Der Repe, J., Van Veldhuiezen, G.: Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid and nalidixic acid. Antimicrobial Agents and Chemotherapy 1983, 24: 302–304.
Eliopoulos, G. M., Gardella, A., Moellering, R. C.: In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agents. Antimicrobial Agents and Chemotherapy 1984, 25: 331–335.
Fass, R. J.: In vitro activity of ciprofloxacin (Bay O 9867). Antimicrobial Agents and Chemotherapy 1983, 24: 568–574.
Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saavedra, S., Ramírez-Ronda, C.H. & Nevárez, M. Ciprofloxacin in the treatment of urinary tract infections caused byPseudomonas aeruginosa and multiresistant bacteria. Eur. J, Clin. Microbiol. 5, 255–257 (1986). https://doi.org/10.1007/BF02014004
Issue Date:
DOI: https://doi.org/10.1007/BF02014004